Relationship between CT characteristics and human epidermal growth factor receptor 2 expression in gastric cancers
- 17 June 2020
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Academic Radiology
- Vol. 3 (3) , 137-142
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81701652)
This publication has 23 references indexed in Scilit:
- Stomach cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 studyCancer, 2017
- 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trialThe Lancet, 2017
- Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric CarcinomaThe Scientific World Journal, 2016
- Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric CancerJournal of Nuclear Medicine, 2016
- Trastuzumab in the Treatment of Breast CancerBioDrugs, 2016
- Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot studyBMC Cancer, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Assessment of a HER2 scoring system for gastric cancer: results from a validation studyHistopathology, 2008
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisOncogene, 2007